Teleconferência de Resultados do 3º Trimestre de 2026 da Benchmark Electronics (BHE): Receita Recorde e Elevação de Perspectivas

Principais destaques

• A Benchmark Electronics registrou receita recorde no 3T2026 de US$ 811 milhões, alta de 19% na comparação anual, superando o limite superior do guidance anterior da administração.
• O LPA diluído não-GAAP aumentou 35% na comparação anual, para US$ 0,84, enquanto a margem operacional não-GAAP expandiu 70 pontos-base, para 5,5%.
• O crescimento foi amplo: a receita de equipamentos de capital para semicondutores subiu 30%, AC&C aumentou 50%, o segmento industrial cresceu 13% e o médico avançou 9% na comparação anual.
• A administração elevou suas projeções para o quarto trimestre e para o ano todo. Agora ela espera que a receita de 2026 supere US$ 3 bilhões, representando um crescimento anual de aproximadamente 16%.
• A receita do 4T está projetada entre US$ 815 milhões e US$ 855 milhões, com LPA diluído não-GAAP de US$ 0,85 a US$ 0,91.
• A administração espera que o momento positivo em equipamentos de capital para semicondutores continue em 2027, enquanto as recentes conquistas de programas devem fazer com que os setores aeroespacial e de defesa retornem ao crescimento no próximo ano.

Principais Resultados Financeiros

Desempenho de Negócios e Operacional

O segmento de equipamentos de capital para semicondutores foi um grande impulsionador do crescimento. A receita aumentou 30% na comparação anual e 8% na comparação trimestral, sustentada pela demanda dos mercados finais e novas conquistas de programas. A administração afirmou que as conversas com clientes apontam agora para uma visibilidade da demanda se estendendo até 2029 e 2030, embora essa visão reflita previsões dos clientes e não um guidance firme da empresa. A Benchmark espera que o crescimento anual do segmento se acelere ainda mais no 4T e continue em 2027.

A receita de AC&C aumentou 50% na comparação anual e 4% na comparação trimestral, impulsionada por uma forte aceleração de produtos on-premise. A Benchmark expandiu sua capacidade fabril para atender à demanda acelerada dos clientes e espera um aumento sequencial relevante na receita no 4T. As perspectivas não incluem contribuições de oportunidades em HPC de última geração, as quais a administração acredita agora que devam começar entre meados e o final de 2027.

A receita do segmento industrial aumentou 13% na comparação anual e 7% na comparação trimestral. A melhoria refletiu principalmente a entrada em produção de programas conquistados anteriormente, incluindo os programas de transferência de produção ("lift-and-shift") discutidos previamente. A administração espera um crescimento comparável na comparação anual no 4T e um crescimento na faixa de média a alta de um dígito no acumulado do ano.

A receita do segmento médico cresceu 9% na comparação anual e 3% na comparação trimestral, impulsionada pelo avanço de programas. A administração espera um crescimento de dois dígitos no acumulado do ano e destacou um contrato significativo concedido por um novo cliente de dispositivos médicos, o maior contrato individual de novos negócios conquistado pela Benchmark durante o 3T. Como os programas médicos exigem tempo para alcançar ritmo pleno de produção, a administração espera que o novo contrato contribua em um horizonte de mais longo prazo, estendendo-se até 2028 e além.

A receita do segmento aeroespacial e de defesa recuou 1% na comparação anual, mas subiu 15% na comparação trimestral. A administração atribuiu a pausa em 2026 ao cronograma dos programas, após um crescimento anual de aproximadamente 20% em cada um dos dois anos anteriores. O recorde de reservas (bookings) no 2T e conquistas adicionais no 3T devem sustentar um retorno ao crescimento em 2027, especialmente em defesa e espaço.

A Benchmark afirmou que possui capacidade suficiente para apoiar o crescimento até 2027. Sua unidade PT4 entrou em operação em julho de 2026 e está atendendo à demanda de semicondutores. A previsão para a conclusão das instalações planejadas na Tailândia é o final de 2027.

Guidance da Administração

Para o ano de 2026, a administração espera que a receita supere US$ 3 bilhões, o equivalente a um crescimento anual de aproximadamente 16%. Os investimentos em capital permanecem projetados entre 2% e 2,5% da receita.

A administração também reiterou seu objetivo de que o crescimento dos lucros fique em 1,5 a 2 vezes a taxa de crescimento da receita em 2026. Com base nos resultados do 3T e no ponto médio do guidance para o 4T, a empresa afirmou que continua posicionada para atingir essa meta.

Riscos e Áreas de Atenção

• As restrições na cadeia de suprimentos continuam presentes. A administração citou desafios persistentes que começaram nos componentes de memória e se espalharam para outras categorias, especialmente suprimentos relacionados a ASICs.
• A Benchmark está investindo seletivamente em estoques junto a clientes para suportar a demanda e o avanço de programas. Isso pode aumentar as necessidades de capital de giro, mesmo com a empresa buscando um giro de estoque de longo prazo de 5 a 5,5 vezes.
• O cronograma do HPC de última geração foi postergado, com contribuições agora esperadas entre meados e o final de 2027, em vez do início do ano.
• O crescimento de AC&C e outras mudanças no mix do portfólio podem anular parte dos benefícios de margem decorrentes dos maiores volumes de equipamentos de capital para semicondutores e das eficiências operacionais.
• O crescimento nos setores aeroespacial e de defesa continua dependente do cronograma dos programas plurianuais concedidos recentemente.

Destaques das Perguntas e Respostas dos Analistas

A administração atribuiu sua confiança no crescimento para 2027 às previsões dos clientes, discussões em andamento e expansões de programas originadas das reservas fechadas em 2025 e 2026. A empresa afirmou que as expansões estão em andamento em 11 instalações globais.

Quanto à capacidade, a administração afirmou que a estrutura fabril atual deve atender à demanda até 2027. A abertura da PT4 em julho de 2026 fortaleceu a capacidade da Benchmark de atender aos clientes de equipamentos de capital para semicondutores, enquanto a empresa continua avaliando a capacidade em sua rede global.

Quanto às margens, a administração espera novas eficiências na margem bruta à medida que novas instalações e programas ganhem escala. A menor remuneração variável também pode trazer benefícios em 2027, embora o mix do portfólio possa compensar parcialmente esses ganhos.

A administração declarou que o crescimento em equipamentos de capital para semicondutores reflete tanto a recuperação ampla do mercado quanto o ganho de participação de mercado. A Benchmark continuou conquistando programas durante a desaceleração do setor iniciada em 2023, incluindo novos contratos com clientes existentes e a adição de novos clientes.

Transcrição Completa da Teleconferência de Resultados

Transcrição completa da teleconferência de resultados

Comentários da administração

Operator

Hello, everyone. Thank you for joining us, and welcome to the Benchmark Electronics Q3 2026 Earnings Call. After today's prepared remarks, we will host a question-and-answer session. [Operator Instructions] I will now hand the conference over to Paul Mansky, Benchmark Investor Relations.

Paul Mansky

Thank you, Percy, and thank you, everyone, for joining us today for Benchmark's Third Quarter 2026 Earnings Call. With us today are David Moisodis, our President and CEO; and Bryan Schumaker, our CFO.

After the market closed, we issued an earnings release pertaining to our financial performance for the quarter along with the presentation, which we will reference on this call. Both are available under the Investor Relations section of our website.

This call will be webcast live with a replay available approximately hour after we conclude -- the company has provided a reconciliation of our GAAP to non-GAAP measures in the earnings release as well as in the appendix to the presentation.

Please take a moment to review forward-looking statements disclosure on Slide of the presentation. During our call, we will discuss forward-looking information. As a reminder, any of today's remarks, which are not statements of historical fact are forward-looking statements, which involve risks and uncertainties as described in our press releases and SEC filings.

Actual results may differ materially from these statements. Benchmark undertakes no obligation to update any forward-looking statements. For today's call, David will start with highlights from the quarter, followed by Bryan who will provide more detail on our results and our guidance, will then return to David for his perspective on sector trends and closing remarks before opening for Q&A. I'll now refer you to Slide as we turn the call over to our CEO, David Moezidis. David?

David Moezidis

Thank you, Paul. Good afternoon, and thank you for joining us today. I'm pleased to report another strong quarter for Benchmark.

Demand continued to improve across much of our portfolio. Our teams executed well and we delivered record revenue alongside earth that significantly outpaced sales.

Let me quickly recap the quarter. Revenue and EPS both came in above the high end of prior guidance. Revenue of $811 million was a record for Benchmark and increased 19% year-over-year. EPS of $0.84, increased 35%, nearly twice the rate of revenue growth.

Our operating margin improved 70 basis points from the prior year, demonstrating the leverage potential in our model. We also maintained discipline around working capital in support of growth, resulting in a 30% year-over-year improvement in cash cycle days.

Looking ahead, demand continues to improve across most of our markets, supported by healthy bookings activity and strong engagement from our customers.

Given the acceleration we expect to maintain throughout the back half, this gives us the confidence to raise our outlook for the fourth quarter and the full year as we now expect 2026 revenue to exceed to $3 billion.

Let me share a few additional highlights from the quarter shown on Slide Over the last several years, we have transformed our go-to-market approach to engage more effectively with both existing and prospective customers. We are now seeing that translate into growth across a broader portion of the portfolio.

Semi cap and ACMC again delivered significant growth while medical remains on pace to deliver double-digit growth for the year. Industrial has also begun to turn the corner, and it is encouraging to see that progress reflected in the results.

Meanwhile, A&D is performing as expected in the 2026 with recent bookings and program wins positioning the sector to return to growth in 2027. We continue to see healthy bookings momentum across the portfolio.

In Q2, A&D led our bookings performance. In Q3, the strongest contributions came from medical, industrial and semi cap. That is the advantage of a balanced portfolio, different sectors will lead at different times.

But the common thread is we are winning business and converting those wins into growth. Our commitment to customer success is equally evident in our operations.

A recent example involved a key AI infrastructure customer that needed additional capacity on a compressed time line. Our teams moved quickly to expand our manufacturing footprint, support the customers' requirements and successfully execute the ramp.

This is the type of responsiveness and execution that strengthens customer relationships and creates additional opportunities for Benchmark. Financial discipline remains just as important.

Last quarter, we said we intended to grow earnings at 1.5 to 2x the rate of revenue growth in 2026. Based on our Q3 performance and the midpoint of our Q4 guidance, we are well positioned to deliver on that commitment. We are also managing this acceleration in growth while strengthening the balance sheet and generating free cash flow.

At the same time, we will continue investing where we see attractive opportunities. That includes investments in capacity and capabilities, such as PTI and Penang, which is ramping well and our planned building in Thailand, which is expected to be completed in late 2027.

As additional opportunities emerge, whether organic or otherwise, we will continue to invest with discipline and a clear focus on returns. With that, I'll turn the call over to Brian to walk through the financial details for the quarter. Brian?

Bryan Schumaker

Thank you, David, and good afternoon, everyone. Please turn to Slide 6. Revenue for the quarter was $811 million, up 19% year-over-year, and non-GAAP EPS was $0.84, up 35% year-over-year.

Both exceeded the high end of guidance from our last earnings call. As a reminder, our non-GAAP results exclude certain items as detailed in Appendix 1 of this presentation.

For the third quarter, non-GAAP gross margin was 10.5%, improving 40 basis points year-over-year and in line with the prior quarter.

Non-GAAP operating margin was 5.5%, improving 70 basis points year-over-year and 30 basis points sequentially. The improvement reflected favorable mix, higher revenue and expense efficiencies partially offset by higher variable compensation.

Our third quarter non-GAAP effective tax rate was 24.9%. Please turn to Slide 7 for revenue performance by sector.

Semi cap revenue grew 30% year-over-year and 8% sequentially, attributed to strong end market demand and new program wins. Industrial revenue increased 13% year-over-year, primarily due to new program awards from key existing customers.

Sequentially, Industrial revenue grew 7%. We are particularly pleased with that result given the onetime revenue benefit in Q2 that we discussed on our prior earnings call.

Meanwhile, medical revenue grew 9% year-over-year and 3% sequentially, primarily due to program ramps. Within AC&C, revenue grew considerably, up 50% over the prior year and 4% versus the June quarter.

Finally, although A&D was down 1% year-over-year, sequential performance was strong at 15% growth. Please turn to Slide 8 for our trended non-GAAP financials.

In Q3, we delivered year-over-year and sequential improvement in revenue, profitability and earnings, reflecting disciplined execution and favorable mix.

Please refer to Slides 9 and 10 for an update on our balance sheet, cash flow and working capital performance. We continue to improve on our already strong balance sheet and giving us the flexibility to invest in growth at an attractive cost of capital.

We will continue to maintain a disciplined approach to our capital allocation decisions. We ended the quarter with $291 million of cash and $133 million net of debt.

During Q3, we added a $45 million revolver in Malaysia as part of our global cash management initiative, bringing our total available borrowing capacity to $576 million.

In the third quarter, we generated $30 million in operating cash flow and $14 million in free cash flow while continuing to invest strategically in inventory, capacity and capabilities to support future growth.

During the quarter, we returned $14 million to investors through dividend and share repurchases. Capital expenditures were approximately $15 million in Q3, primarily supporting growth initiatives across the business.

For the full year, we continue to expect capital spending to be in the range of 2% to 2.5% of revenue. Turning to working capital. Our cash conversion cycle improved to 54 days, 23 days better year-over-year and 5 days better sequentially.

Our team continued to actively manage the full range of working capital levers. Although individual components can move quarter-to-quarter, disciplined execution across the portfolio drove this improvement.

Please turn to Slide 11 for our fourth quarter guidance. For the fourth quarter of 2026, we are guiding revenue to a range of $815 million to $855 million. This represents 19% year-over-year growth at the midpoint.

For the full year, we expect 16% annual growth, now exceeding $3 billion. We forecast non-GAAP diluted earnings per share in the range of $0.85 to $0.91. We anticipate non-GAAP gross margin of 10.5% to 10.7%, and non-GAAP operating margin of 5.5% to 5.7%.

GAAP expenses are projected to include approximately $7.8 million of stock-based compensation and $2.7 million to $3.2 million of nonoperating expenses, including amortization, restructuring and other charges.

Interest and other expenses are assumed to be approximately $3.8 million. We are starting to see progress on our initiatives to structurally lower our tax rate. For the fourth quarter, we anticipate an effective tax rate in the range of 25% to 26%.

Finally, for the quarter, we project weighted average diluted shares outstanding of approximately 36.4 million. With that, I would like to turn the call back over to David for our outlook by market sector and closing remarks. David?

David Moezidis

Thank you, Brian. Turning to Slide 12. Let me provide some color on the perspective of outlook by sector.

Similar to last quarter, we saw semi-cap demand improved throughout the quarter as the industry continued investing in additional capacity. At this time last year, I had just returned from SEMICON West and shared that we were seeing more tangible support for an industry upturn in 2026, that view has clearly played out across the market and within our business.

Following this year's event, the message has shifted from recovery to durability. Industry participants are now discussing demand visibility extending into 2029 and 2030.

We are seeing that strengthen our customer forecast and have plans underway to grow with our customers. We expect semi cap revenue to accelerate further year-over-year in the fourth quarter, followed by continued growth in 2027.

Industrial delivered another strong quarter, growing 13% year-over-year. We expect that pace to continue in Q4, positioning the sector to deliver mid- to high single-digit growth for the full year compared with our initial expectations for relatively flat performance.

We have remained confident in our industrial strategy and that our sector performance would improve as awards move into production. We are pleased to see this starting to reflect in the results. The demand environment across our industrial end markets appears healthy.

However, the primary driver of our improved outlook is the conversion of prior bookings into revenue, including several lift-and-shift programs we had previously discussed.

With the strong bookings performance we delivered in Q3 and expect to do so in Q4, we like how the Industrial business is positioned today.

In aerospace and defense, I continue to be pleased with the pace and quality of our new wins. A&D bookings reached a company record in the second quarter, followed by another solid performance in Q3. Demand remains robust, particularly within the defense and space subsectors.

We have said throughout the year the approximate 20% annual growth delivered by A&D over the past 2 years with pause in 2026, primarily because of program timing, that continues to be the case. However, as recently awarded programs begin to ramp and given the multiyear nature of these markets, we expect A&D to return to growth in 2027.

Medical continues to perform well. We have executed effectively against new program ramps over the past several quarters and remain on pace to deliver double-digit growth for the year.

That would represent an acceleration from high single-digit growth in 2025. Medical was also one of our strongest bookings contributors in the quarter. That performance included a significant program with a new medical device customer, representing the largest individual piece of new business awarded to Benchmark during Q3.

This is another example of the breadth of new business we are winning across the portfolio and the opportunity we have to build on our medical momentum over time.

Finally, AC &C delivered another outstanding quarter with an impressive 50% year-over-year growth, driven by a major ramp that began earlier this year. This was aided by the manufacturing footprint expansion discussed earlier, which positions us to support a material sequential increase in AC&C revenue in the current quarter.

Our current outlook assumes no contribution from next-generation HPC opportunities, which today appear more likely to begin contributing mid- to late 2027.

Turning to Slide 13. I would like to leave you with a few closing thoughts. As I step back and look at where we are today, what stands out is the accelerating depth and breadth of our customer wins versus just a couple of years ago.

Demand is strengthening, bookings remain healthy, and our teams continue to execute well. That is increasing our confidence in the balance of 2026 and positioning benchmark for continued growth in 2027 as we execute on our many program ramps around the world.

We are also maintaining the operating discipline that has allowed earnings to grow faster than revenue while continuing to generate cash and strengthen the balance sheet. We will continue investing in capabilities where we see attractive returns.

We will also support customers in other ways, including targeted inventory investments when necessary to help meet demand and execute program ramps. Our objective is straightforward. Help our customers succeed, grow profitably and create long-term value for our shareholders. Based on what we are seeing across the business today, I believe Benchmark is well positioned to continue doing exactly that. Before we open up the call for questions, I would like to thank our customers for their trust, our shareholders for their support and our employees around the world for their dedication and execution.

Our performance reflects their efforts, and I appreciate everything they have done to position Benchmark for continued success. Operator, we can now open the call for questions.

Operator

We will now begin the question-and-answer session. [Operator Instructions] The first question comes from the line of David Williams with Needham. David.

Perguntas e respostas

David Williams

Good evening, everyone, and thanks for -- and first, let me just offer my congratulations on the strong results here. Clearly, you're seeing a tremendous amount of demand coming through.

And if we kind of think about stability into 2027, and you talked about this a bit in your script. But can you help us kind of work through how you get confident with that growth outside of maybe just your customer forecast? Is it the demand environment? Is it just firming of those customer forecast? Or are there other things maybe that are giving you that increased confidence?

Bryan Schumaker

Yes. It's a good question, David. And I think there is a few elements that kind of leads to that. One, naturally, is the customer forecast. It gives us certain visibility out into 2027 naturally.

The other aspect of it that gives us confidence is we've got a number of ramps that are in progress right now as a result of the bookings that we had not only early in 2026, but the bookings that we had in 2025 as well given ramps take some time to materialize.

The third part of it is that we're having customer conversations quite often and really trying to understand what our customer needs are and what their views are.

And as a result of that, we're leaning in and saying, we're going to continue this momentum, and we see no reason why this momentum doesn't continue for us.

David Williams

Good. I just want to ask maybe about your capacity. And obviously, you have an and Thailand is coming up next year. But if you think about this demand acceleration, do you feel comfortable with your current footprint and your ability to meet this demand? Or do you see constraints may be coming in from a capacity standpoint as this builds?

Bryan Schumaker

No, it's a great question. We feel comfortable we're constantly looking at capacity, not just Penang in Thailand, but we're looking at capacity all around the world.

And we feel comfortable that we've got capacity to take us through 2027. And one of the things that we had done, David, as you may recall, we invested in PT4 and that decision was made in December of 2024, and that factory came online in this past summer.

It was in July, actually, July 2026. And just that in itself has positioned us really, really well, particularly for the semiconductor growth that we're seeing.

David Williams

Okay. Great. And 1 more, if you don't mind me squeezing in. But -- the leverage is clearly coming through the business and getting a lot of benefits. As we kind of move forward here, how much leverage do you think is still left in the business just from kind of the volume, the volume aspect of that? And where are the pieces of execution do you think that are left that can drive that margin incrementally better as you move through '27?

David Moezidis

Yes. So if you look at the top line, the gross margin piece of it, part of it are the major ramps that we have going across the globe, some of that piece of it that are impacting us that we will continue to drive efficiencies as we move out, building the capacity that we have.

From an operating standpoint, I mean, we feel good about where we're at. We talked about the variable comp headwind this year. and we'll have some benefit from that next year, just thinking through that line item. So -- and we got other initiatives going on that will continue to improve that. So we feel good about our leverage and continuing into next year with that $1.5 billion to $2 billion revenue percentage flowing through to the bottom line.

So just putting that in perspective, that's still what we're targeting.

David Williams

Okay. Fantastic.

Bryan Schumaker

Yes. Thanks, David. David, glad to see you on board with coverage.

Operator

The next question comes from the line of Steven Fox with Fox Advisors.

Steven Fox

A couple of questions from me. I guess, first of all, David, you talked about the durability of semi-cap demand into '29, '30 based on what you're hearing.

But what about just ruling it into next year. Do you expect to see more momentum off of the numbers you're posting now? Any changes in mix, pricing, et cetera, that you talked about with semi cap? And then I had a follow-up.

David Moezidis

Stephen, we do -- we see the momentum continuing into 2027. Naturally, some of that momentum is going to be tied to ramps that we've got going on as well.

Even in the semi space, there's ongoing ramps filling in PTI. But that said, we feel really positive about semi.

Steven Fox

And in terms of, I guess, the margins you're looking at continuing to improve sequentially -- as we think about next year, any thoughts on continuing to get operating leverage? I guess from 2 perspectives: one, because you're adding capacity now.

Is there a way to talk about how much sort of margin is being held back by those capacity additions? And then secondly, how maybe your mix could help you next year. So without diving into the numbers, maybe directionally some of the factors that help as you get into the new year.

Bryan Schumaker

Yes, you're right. I mean we do expect continued margin efficiency at the gross margin line into next year as we continue to ramp up the PGI and some of those other ramps. As far as directionally, I mean I can't give you a fixed number, but we do see that flowing through on that line item so and the other contrary to that is, as you see on the AC &C and some of the benefit there.

So with semi-cap going, you've also had some mix items there that can also kind of counterbalance that. So just putting it in perspective, we'll give more guidance in the future on this into the next Q4 call as far as '27 goes, but you do have some of those working against us, too, as you think about margin across the whole portfolio and the growth that we're seeing.

Steven Fox

Okay. And then just off of that, I'm not quite sure I understand followed everything on ACC. So you're talking about a footprint expansion that's going to lead to growth in AC&C, but can you -- I guess, what kind of products are you talking about? Like what's the timing of that look like to start factoring that into our thinking.

David Moezidis

Yes. You're actually seeing some of those benefits already, Stephen. And the products that we're speaking to are the on-prem products that we've discussed in prior calls.

So we're seeing that ramp accelerate and accelerate it so fast that we actually expanded our capacity to meet the customers' demands and we've done that successfully, quite honestly, and we see it continuing -- we see that momentum continuing into '27, as well as core Q4, as I mentioned on the call.

Operator

Your next question comes from the line of Max Millis with Lake Street Capital Markets.

Maxwell Michaelis

Probably just a quick clarification. Last quarter in the presentation, you guys noted late Q4, early 2027, early production this presentation, you're talking about ramping mid to late 2027 and then some of the other comments you've made about ACC. Are these all the same projects you've been talking about? Or is there another opportunity here that was layered in? Just help me clarify that at the talk.

Bryan Schumaker

Yes. Max, the HBC will layer on top of what we're doing and what we've been saying and as I mentioned last quarter as well, we're staying really close to that, and it's a timing thing with our end customer.

And the latest updates that we have is it shifted a bit further out, just to touch and so we thought that we'd provide an update on that given the updates that we have. But at the end of the day, that HVC goes on top of everything else we're already doing.

So we're very encouraged by the fact that it's going to start picking up mid- to late '27. But we'll keep you posted on that.

Maxwell Michaelis

No. And you guys didn't mention anything, I don't think about supply chain issues in the call today. I mean is there anything that your customers have been relating to you guys that you could foresee kind of going into 2027 that you're thinking about?

Bryan Schumaker

Yes. So supply chain issues are there. There's no denying that, right? I've been talking about it for 3 quarters. It started with the memory and then it's now somewhat spilled into some other categories, but mostly the ASIC side of the supplies where we're seeing some of the challenges.

Now that said, we're working very, very closely, Max, with our suppliers as well as our customers to work through the issues. And one of the comments I made in the script was we're making selective investments ahead with our customers with these are customer conversations and joint decisions, so we can position the inventory properly for their business needs.

Maxwell Michaelis

Perfect. Last 1 for me. You talked about semi durability out to 2029. That seems, I mean in terms of visibility, it seems far out. I mean is this a lot -- the market right now in terms of semi, let's call it, is it a lot different than you've seen it historically, just the way customers are behaving in terms of forecast. I mean kind of help me out here.

Bryan Schumaker

Look, I -- as I mentioned, I'm reflecting the optimism and inputs directly from our customers, right? And they speak very openly and publicly on it. There's interviews out there, obviously, in and some of their outlooks that they've provided, they're taking longer orders than perhaps in the past.

So that is different but that's also a positive because it gives them a longer view and that longer view allows them to work closely with us, so we can position the supply chain to meet their needs.

So fundamentally, I strongly believe it's a plus. The durability comes straight from our customer base, words like big and sustaining comes from our customer base. So we listen very closely. I'm very active with the senior executives at all of our customers and what I'm relaying is exactly the dialogues that I've had.

Maxwell Michaelis

Perfect. All right, guys. That's it for me.

Bryan Schumaker

Thanks. Thanks, Max.

Operator

Your next question comes from the line of Anja Soderstrom with Sidoti.

Anja Soderstrom

Last quarter, Mostanad been directed already. But just in medical, what are you seeing there? And actually we think about the sustained demand there?

Bryan Schumaker

Yes. So -- we're actually really positive on medical. And as you may recall, it was summer of 2025 when I got on the call and I said I think the bottom is in for medical, and it certainly has been and it's been climbing sense.

The first part of that climb has been attributed to wins as well as the base customer demand starting to pick up.

So that's been really, really beneficial to the performance that we've seen in medical.

Now as we look forward, we continue to remain positive on medical, and we still have some ramps that are in the process. And as those ramps materialize, we think medical could potentially continue beyond '27 and into '28.

The other thing that was very positive I shared is we won a pretty significant piece of business with a medical device customer. And it's going to take time to ramp. However, once it ramps, I think it will again put us in a really, really good position for Medical, again, looking '28 and beyond for that ramp to materialize as medical takes time.

Anja Soderstrom

Okay. That was helpful. And then how should I think about cash flow and capital allocation priorities?

David Moezidis

Yes. So I mean, as you noted, we noticed we did buy back some more shares this last quarter. We continue to do that with the dividend. We feel great about our cash position right now and where we sit with the free cash flow of $113 million over the last 12 months, and we expect it in Q4, too.

So we're well positioned with where we're at. And again, the cash conversion cycle and what we were able to do there. The one thing is on the inventory, and we'll continue to focus on the 5 turns. It slipped a little bit this quarter.

But again, as we -- with the ramps and everything going on, we expect some of that, but we're going to, again, long-range target the inventory with turns of 5 to 5.5, so...

Anja Soderstrom

Okay. That was all for me.

Operator

Your next question comes from the line of David Williams with Needham.

David Williams

Let me ask a follow-up. And maybe just on that last question there. On the inventory side, it looks like your inventory is up about 16% sequentially, a little higher than what your growth was if we kind of think about that as being maybe relative to the growth that you're preparing for going forward? Or is there anything within that inventory that we should be thinking about in terms of maybe higher pricing that you just haven't been able to recover from customers yet? or anything else that we need to be considering?

Bryan Schumaker

Yes. David, welcome back. What I would tell you is the inventory is lifting as a result of the ramps and the number of bookings that we've had.

I think we looked around the globe, and we have ramps going on at 11 of our sites around the world.

And obviously, that's going to create some inventory lift. But we're staying really, really disciplined with regards to inventory and making sure that we manage it carefully and we watch our turns carefully, and the correlation is tied directly to the ramps.

David Williams

Okay. And just 1 last quick one. On the semi cap side, is there a way to disaggregate maybe the underlying demand versus where you've won share or where you're benefiting outside of just the cyclical demand environment?

Bryan Schumaker

It's a tough question to answer because we've been winning in semiconductor capital equipment since '23 since it was going through, it's a bit of a slowdown.

And during that time, we were winning programs from our customers and positioning ourselves for when the industry turns. And we're fortunate that the industry started turning around January as we started signaling that we saw a turn coming.

But fundamentally, we have on share across the portfolio from our existing customers that have been with us quite some time, and we also added on some new logos along the way.

David Williams

Thanks much, and best luck in the quarter to, appreciate it.

Bryan Schumaker

Thank you, David. Thank you.

Operator

There are no further questions at this time. I will now turn the call back to Paul Mansky, for closing remarks.

Paul Mansky

Thank you, Percy, and thank you, everyone, for participating in Benchmark's Third Quarter 2026 Earnings Call. Between now and our next call, we have a number of planned events. First up, this coming Monday, we'll be at the NYSE to ring the closing bell ahead of our 30th year listed on the exchange.

The following week, we'll be attending the Baird Industrials Conference in Chicago on the 11th. In December, we'll be attending conferences on both the seventh and the eighth, starting with Raymond James TMT and Consumer Conference in New York, followed the next day on the West Coast with wells at their Annual TMT Conference in L.A. rounding that out on January 1, we'll be back in New York on the 29th at the -- excuse me, back in New York on the 11th for the 29th Annual Meet of Growth Conference.

For updates to these and other conferences and events, please refer to the Events section of our website at ir.bench.com. With that, thank you again for your support, and we look forward to speaking with you soon.

Operator

This concludes today's call. Thank you for attending. You may now disconnect.